Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.61 |
| ▸ | PI4KA | P42356 | 8/20 | 0.57 |
| ▸ | PI4K2B | Q8TCG2 | 8/20 | 0.57 |
| ▸ | PI4K2A | Q9BTU6 | 8/20 | 0.57 |
| ▸ | PI4KB | Q9UBF8 | 8/20 | 0.57 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454410 | 1.00 | ADORA2A (0.61) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL2639251 | 0.79 | ADORA2A (0.37) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL42314 | 0.79 | ADORA2A (0.66) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL29400753 | 0.79 | ADORA2A (0.66) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL30109321 | 0.78 | NUDT1 (0.68) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL1059581 | 0.78 | NUDT1 (0.68) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL843169 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL842891 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL11918991 | 0.76 | NUDT1 (0.36) | ADORA2AADORA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL842440 | 0.76 | ADORA2A (0.61) | ADORA2AADORA1PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4042 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630827-B2 | Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies | ROGCON, INC. (US) | 2026-05-19 | — | — | US | claimed |
| US-20250257360-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | UNIV OKLAHOMA (US) | 2025-08-14 | — | — | US | claimed |
| CN-113151261-B | Antisense oligonucleotides as inhibitors of TGF-R signaling | 神经视觉医药有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250179503-A1 | METHODS OF USING OLIGOMERIC COMPOUNDS TO TREAT SCN2A-RELATED DISORDERS | PRAXIS PREC MEDICINES INC (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025110816-A1 | COMBINATION THERAPY OF ANTICANCER TREATMENT WITH TOLL-LIKE RECEPTOR 7 OR 8 AGONIST HAVING ACTIVE SITE TEMPORARILY INACTIVATED FOR CANCER TREATMENT | 프로지니어 주식회사 | 2025-05-30 | — | — | WO | claimed |
| US-20250146073-A1 | METHODS FOR THE TREATMENT OF SCN2A-RELATED DISORDERS | PRAXIS PREC MEDICINES INC (US) | 2025-05-08 | — | — | US | claimed |
| EP-4506456-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | Lin, Shi-Lung (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4504945-A2 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | The Board of Regents of the University of Oklahoma (US) | 2025-02-12 | — | — | EP | claimed |
| US-12215343-B2 | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-04 | — | — | US | claimed |
| US-20250019709-A1 | NOVEL OXO-RNA COMPOSITIONS AND THE RELATED APPLICATIONS THEREOF | LIN SHI LUNG (US) | 2025-01-16 | — | — | US | claimed |
| US-6566514-B1 | Antisense oligonucleotides for use in the treatment of tumors | GENESENSE TECHNOLOGIES INC. (CA) | 2003-05-20 | — | — | US | claimed |
| US-6548252-B1 | Electrochemically analyzing samples from selected areas of the body of a living organism for elevated free levels of nucleotide excision products resulting from DNA or RNA damage | ESA, INC. | 2003-04-15 | — | — | US | claimed |
| US-6187551-B1 | HYBRIDOMA CULTURE PRODUCT | CYTOCHEM, INC. | 2001-02-13 | — | — | US | claimed |
| EP-0898575-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KÖSTER, Hubert (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0706581-A4 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOU (US) | 1999-02-10 | — | — | EP | claimed |
| WO-1997041139-A2 | A COMBINATORIAL PROTECTING GROUP STRATEGY FOR MULTIFUNCTIONAL MOLECULES | KOESTER HUBERT (US) | 1997-11-06 | — | — | WO | claimed |
| US-5665553-A | Methods for determining and modulating cellular redox potential and genotoxic states | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1997-09-09 | — | — | US | claimed |
| US-5601981-A | ASSAYING DNA FROM TEST SPECIMEN FOR CONCENTRATION OF RING-OPENED AND HYDROXYL DERIVATIVES, COMPARING, WHEREIN REDUCTIVE CELLULAR REDOX POTENTIAL EXISTS WHEN FORMATION OF RING-OPENED OVER HYDROXYL DERIVATIVES IS FAVORED | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1997-02-11 | — | — | US | claimed |
| EP-0706581-A1 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1994025626-A1 | DNA PROFILES AS AN INDICATOR OF CELLULAR REDOX POTENTIAL AND CANCER RISK | PACIFIC NORTHWEST RESEARCH FOUNDATION (US) | 1994-11-10 | — | — | WO | claimed |